Novo Nordisk AS (NVO)
102.63
-2.64
(-2.51%)
USD |
NYSE |
Nov 21, 16:00
103.50
+0.87
(+0.85%)
Pre-Market: 08:26
Novo Nordisk Debt to Equity Ratio: 0.4727 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.4727 |
| June 30, 2024 | 0.5071 |
| March 31, 2024 | 0.2722 |
| December 31, 2023 | 0.1997 |
| September 30, 2023 | 0.2854 |
| June 30, 2023 | 0.2841 |
| March 31, 2023 | 0.3195 |
| December 31, 2022 | 0.2546 |
| September 30, 2022 | 0.3387 |
| June 30, 2022 | 0.3416 |
| March 31, 2022 | 0.3829 |
| December 31, 2021 | 0.3183 |
| September 30, 2021 | 0.208 |
| June 30, 2021 | 0.2099 |
| March 31, 2021 | 0.1651 |
| December 31, 2020 | 0.1056 |
| September 30, 2020 | 0.0689 |
| June 30, 2020 | 0.069 |
| March 31, 2020 | 0.0756 |
| December 31, 2019 | 0.0114 |
| September 30, 2019 | 0.082 |
| June 30, 2019 | 0.0797 |
| March 31, 2019 | 0.0913 |
| December 31, 2018 | 0.0099 |
| September 30, 2018 | 0.0071 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.005 |
| March 31, 2018 | 0.0052 |
| December 31, 2017 | 0.034 |
| September 30, 2017 | 0.0055 |
| June 30, 2017 | 0.0347 |
| March 31, 2017 | 0.0152 |
| December 31, 2016 | 0.0051 |
| September 30, 2016 | 0.011 |
| June 30, 2016 | 0.0095 |
| March 31, 2016 | 0.0109 |
| December 31, 2015 | 0.0228 |
| September 30, 2015 | 0.0146 |
| June 30, 2015 | 0.0188 |
| March 31, 2015 | 0.0185 |
| December 31, 2014 | 0.0179 |
| September 30, 2014 | 0.0075 |
| June 30, 2014 | 0.0111 |
| March 31, 2014 | 0.0239 |
| December 31, 2013 | 0.0051 |
| September 30, 2013 | 0.0171 |
| June 30, 2013 | 0.0203 |
| March 31, 2013 | 0.0089 |
| December 31, 2012 | 0.0123 |
| September 30, 2012 | 0.0306 |
| June 30, 2012 | 0.0284 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0114
Minimum
Dec 2019
0.5071
Maximum
Jun 2024
0.2445
Average
0.2634
Median
Debt to Equity Ratio Benchmarks
| Ascendis Pharma AS | -8.104 |
| Amgen Inc | 8.024 |
| AstraZeneca PLC | 0.7402 |
| Grifols SA | 0.00 |
| Viking Therapeutics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 59.53B |
| Total Liabilities (Quarterly) | 41.48B |
| Shareholders Equity (Quarterly) | 18.05B |
| Current Ratio | 0.9367 |
| Net Debt Paydown Yield | -0.18% |